Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Market Closed - Toronto S.E.
Other stock markets
 15:58:41 2024-06-20 EDT 		5-day change 1st Jan Change
0.59 CAD +7.27% Intraday chart for Satellos Bioscience Inc. +1.72% +37.21%
05-28 Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment MT
05-28 Satellos Bioscience Inc. Brief: Announcing Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SATELLOS BIOSCIENCE INC.
Bio Therapeutic Drugs
+7.27%+1.72%+37.21%+13.46% - 48.57M
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. Comparison Chart